Jürgen E. Gschwend

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Dean F. Bajorin, J. Alfred Witjes, Jürgen E. Gschwend et al. · New England Journal of Medicine · 2021 · 1K citations · Full text

Medicine, Oncology, Surgery +17

Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

Matthias Eiber, Tobias Maurer, Michael Souvatzoglou et al. · Journal of Nuclear Medicine · 2015 · 995 citations

Medicine, Nuclear Medicine, Radiology +14

Diagnostic Efficacy of ⁶⁸ Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Tobias Maurer, Jürgen E. Gschwend, Isabel Rauscher et al. · The Journal of Urology · 2015 · 783 citations

Medicine, Nuclear Medicine, Oncology +15

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 604 citations

Medicine, Oncology, Urology +12

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

Bernard Escudier, Camillo Porta, Petri Bono et al. · Journal of Clinical Oncology · 2014 · 439 citations · Full text

Medicine, Oncology, Pharmacotherapy +15